News Room
News Room
News Room
Emalex Biosciences Phase 2b Tourette Syndrome Clinical Trial Reaches Enrollment Milestone
– Half of participants are now enrolled in study evaluating ecopipam (EBS-101) as a potential first-in-class treatment for pediatric patients with Tourette Syndrome – [...]
Harmony Biosciences Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
PLYMOUTH MEETING, PA and CHICAGO, IL, August 21, 2020 — Harmony Biosciences Holdings, Inc. (“Harmony”), a pharmaceutical company dedicated to developing and commercializing innovative therapies [...]
Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering
PLYMOUTH MEETING, PA and CHICAGO, IL, August 18, 2020 — Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for [...]
Paragon Biosciences Appoints Kerensa Jimenez as Paragon Health Capital Chief Executive Officer
Chicago, August 12, 2020 – With strong momentum in its growing portfolio of life science companies, Paragon Biosciences announced the appointment of Kerensa Jimenez as [...]
Sterling Bay Signs Lease with Evozyne, LLC at Lincoln Park Life Science Building, 2430 N Halsted
Sterling Bay Signs Lease with Evozyne, LLC at Lincoln Park Life Science Building, 2430 N Halsted Chicago, August 6, 2020 – Sterling Bay, Chicago’s [...]
Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology
Publication in peer-reviewed journal Science demonstrates the foundation of the company’s evolution-based, data-driven engineering technology to build artificial functional enzymes Chicago, July 23, 2020 – A [...]
